on intravenous administration high-clearance drugs generally show reduced systemic clearance predominantly caused by decreased liver blood flow , whereas on oral administration a considerable increase in systemic availability may occur caused by reduced enzyme activity and ( in cirrhosis ) bij portacaval shunting .
C0023884
liver
C0023890
cirrhosis